What are glial cells and why are they important to neurological diseases?
Glial cells, also known as neuroglia, are non-neuronal cells in the central nervous system and provide support and protection for neurons. They're involved in a variety of functions including maintaining homeostasis, forming myelin, providing support and nutrition, and participating in signal transmission in the nervous system.
The importance of glial cells as therapeutic targets lies in their involvement in many neurological diseases. Abnormalities in glial cells are implicated in conditions such as Alzheimer's disease, psychiatric disease, stroke, and multiple sclerosis. Therefore, therapeutics that target glial cells would potentially modify disease progression, provide neuroprotection, or aid in neural repair.
Redefining drug discovery for neuroscience R&D
GliaGenesis is a new company which aim to enhance the health of millions of individuals by identifying new therapeutics for neurodenerative diseases and neuropsychiatric disorders that currently have no effective treatments.
Using a novel computational AI pipeline developed by GliaGenesis, we identify small molecule therapeutics to target both damaged cells in the brain and programming the replacement of new neural cells which will integrate into brain circuits.
Our Mission
GliaGenesis was established to pioneer in silico drug discovery, set to revolutionise our expectations regarding successful treatment of neuropsychiatric and neurodegenerative disorders. We have a streamlined computational strategies that expedite target and therapy identification for diseases that target neurons, oligodendrocytes, astrocytes, microglia and neural stem cells. We are set to to transform the approach to treating notoriously difficult diseases.
Our Collaborators
